Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank33
3Y CAGR+14.5%
5Y CAGR-15.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+14.5%/yr
vs -7.5%/yr prior
5Y CAGR
-15.9%/yr
Recent acceleration
Acceleration
+22.0pp
Accelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $18.91M | -44.5% |
| 2024 | $34.10M | +5.2% |
| 2023 | $32.40M | +157.3% |
| 2022 | $12.59M | -65.8% |
| 2021 | $36.83M | -18.2% |
| 2020 | $45.00M | -21.5% |
| 2019 | $57.31M | +233.9% |
| 2018 | $17.16M | -22.0% |
| 2017 | $22.02M | +165.7% |
| 2016 | $8.29M | - |